BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1494330)

  • 1. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
    Chin YM; Bosco JJ; Koh CL
    Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Philadelphia chromosome positive acute mixed lineage leukemia with bcr (M-BCR-1) rearrangement].
    Okada S; Shimizu T; Harada H; Miyoshi Y; Takizawa Y; Hagiwara S; Mori H; Niikura H; Terada H; Fujita K
    Rinsho Ketsueki; 1990 Jan; 31(1):89-94. PubMed ID: 2156095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor BCR (m-bcr) rearrangements may appear in major BCR (M-bcr)-positive CML cases.
    Karlic H; Grill R; Schlögl E
    Hematol Pathol; 1992; 6(4):203-7. PubMed ID: 1362728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rearrangement and expression of bcr-abl genes in CML and ALL].
    Kunieda Y; Okabe M
    Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ph1-positive leukemia: cytogenetic outline and prognosis].
    Misawa S
    Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of breakpoints on BCR gene in acute leukemia patients with Ph1 chromosome].
    Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohi H; Nakamura Y
    Rinsho Ketsueki; 1992 Jan; 33(1):1-10. PubMed ID: 1545509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
    Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
    Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
    Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
    Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
    Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
    Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular rearrangements of chromosome 22 in chronic myeloid leukemia in a multi-ethnic Malaysian population.
    Bosco JJ; Dyck JA
    Singapore Med J; 1989 Aug; 30(4):363-7. PubMed ID: 2814539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
    Suryanarayan K; Hunger SP; Kohler S; Carroll AJ; Crist W; Link MP; Cleary ML
    Blood; 1991 Jan; 77(2):324-30. PubMed ID: 1985699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Philadelphia chromosome-positive adult acute lymphocytic leukemia].
    Morioka M; Okabe M
    Rinsho Ketsueki; 1991 Apr; 32(4):354-60. PubMed ID: 2067078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia.
    Zaccaria A; Tassinari A; Guerrasio A; Rosso C; Lo Coco F; Diverio D; Testoni N; Celso B; Buzzi M; Tura S
    Haematologica; 1991; 76(3):183-7. PubMed ID: 1660437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.